Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Euro Surveill ; 25(50)2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-33334396

RESUMO

High coronavirus incidence has prompted the Netherlands to implement a second lockdown. To elucidate the epidemic's development preceding this second wave, we analysed weekly test positivity in public test locations by population subgroup between 1 June and 17 October 2020. Hospitality and public transport workers, driving instructors, hairdressers and aestheticians had higher test positivity compared with a reference group of individuals without a close-contact occupation. Workers in childcare, education and healthcare showed lower test positivity.


Assuntos
Distribuição por Idade , Teste para COVID-19 , COVID-19/epidemiologia , Controle de Doenças Transmissíveis/métodos , Ocupações/estatística & dados numéricos , Pandemias , SARS-CoV-2/isolamento & purificação , Adolescente , Adulto , Idoso , COVID-19/diagnóstico , COVID-19/prevenção & controle , Criança , Pré-Escolar , Busca de Comunicante , Feminino , Acessibilidade aos Serviços de Saúde , Hospitalização/estatística & dados numéricos , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Países Baixos/epidemiologia , Exposição Ocupacional , Distanciamento Físico , Quarentena , Risco , Adulto Jovem
2.
Euro Surveill ; 24(18)2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31064637

RESUMO

IntroductionEstimating burden of disease (BoD) is an essential first step in the decision-making process on introducing new vaccines into national immunisation programmes (NIPs). For varicella, a common vaccine-preventable disease, BoD in the Netherlands was unknown.AimTo assess national varicella BoD and compare it to BoD of other vaccine-preventable diseases before their introduction in the NIP.MethodsIn this health estimates reporting study, BoD was expressed in disability-adjusted life years (DALYs) using methodology from the Burden of Communicable Diseases in Europe (BCoDE)-project. As no parameters/disease model for varicella (including herpes zoster) were available in the BCoDE toolkit, incidence, disease progression model and parameters were derived from seroprevalence, healthcare registries and published data. For most other diseases, BoD was estimated with existing BCoDE-parameters, adapted to the Netherlands if needed.ResultsIn 2017, the estimated BoD of varicella in the Netherlands was 1,800 (95% uncertainty interval (UI): 1,800-1,900) DALYs. Herpes zoster mainly contributed to this BoD (1,600 DALYs; 91%), which was generally lower than the BoD of most current NIP diseases in the year before their introduction into the NIP. However, BoD for varicella was higher than for rotavirus gastroenteritis (1,100; 95%UI: 440-2,200 DALYs) and meningococcal B disease (620; 95%UI: 490-770 DALYs), two other potential NIP candidates.ConclusionsWhen considering the introduction of a new vaccine in the NIP, BoD is usually estimated in isolation. The current approach assesses BoD in relation to other vaccine-preventable diseases' BoD, which may help national advisory committees on immunisation and policymakers to set vaccination priorities.


Assuntos
Varicela/epidemiologia , Programas de Imunização , Programas Nacionais de Saúde , Distribuição por Idade , Varicela/prevenção & controle , Doenças Transmissíveis/epidemiologia , Difteria/mortalidade , Avaliação da Deficiência , Progressão da Doença , Feminino , Gastroenterite/epidemiologia , Gastroenterite/virologia , Herpes Zoster/epidemiologia , Humanos , Incidência , Sarampo/mortalidade , Países Baixos/epidemiologia , Poliomielite/mortalidade , Desenvolvimento de Programas , Infecções por Rotavirus/epidemiologia , Distribuição por Sexo , Tétano/mortalidade , Neoplasias do Colo do Útero/epidemiologia
3.
PLoS Negl Trop Dis ; 9(8): e0003995, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26291831

RESUMO

BACKGROUND: Chronic schistosomiasis is associated with T cell hypo-responsiveness and immunoregulatory mechanisms, including induction of regulatory T cells (Tregs). However, little is known about Treg functional capacity during human Schistosoma haematobium infection. METHODOLOGY: CD4+CD25hiFOXP3+ cells were characterized by flow cytometry and their function assessed by analysing total and Treg-depleted PBMC responses to schistosomal adult worm antigen (AWA), soluable egg antigen (SEA) and Bacillus Calmette-Guérin (BCG) in S. haematobium-infected Gabonese children before and 6 weeks after anthelmintic treatment. Cytokines responses (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) were integrated using Principal Component Analysis (PCA). Proliferation was measured by CFSE. PRINCIPAL FINDINGS: S. haematobium infection was associated with increased Treg frequencies, which decreased post-treatment. Cytokine responses clustered into two principal components reflecting regulatory and Th2-polarized (PC1) and pro-inflammatory and Th1-polarized (PC2) cytokine responses; both components increased post-treatment. Treg depletion resulted in increased PC1 and PC2 at both time-points. Proliferation on the other hand, showed no significant difference from pre- to post-treatment. Treg depletion resulted mostly in increased proliferative responses at the pre-treatment time-point only. CONCLUSIONS: Schistosoma-associated CD4+CD25hiFOXP3+Tregs exert a suppressive effect on both proliferation and cytokine production. Although Treg frequency decreases after praziquantel treatment, their suppressive capacity remains unaltered when considering cytokine production whereas their influence on proliferation weakens with treatment.


Assuntos
Anti-Helmínticos/uso terapêutico , Citocinas/metabolismo , Regulação da Expressão Gênica/fisiologia , Praziquantel/uso terapêutico , Esquistossomose Urinária/tratamento farmacológico , Linfócitos T Reguladores/classificação , Adolescente , Antígenos CD4/imunologia , Criança , Estudos de Coortes , Feminino , Fatores de Transcrição Forkhead/imunologia , Humanos , Subunidade alfa de Receptor de Interleucina-2/imunologia , Estudos Longitudinais , Masculino , Fragmentos de Peptídeos/imunologia , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/metabolismo , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA